Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 20, 2013

Primary Completion Date

January 3, 2017

Study Completion Date

January 3, 2017

Conditions
Moderate to Severe Nail Psoriasis
Interventions
BIOLOGICAL

Secukinumab

Study treatment was provided in pre-filled 1 mL syringes.

BIOLOGICAL

Placebo

Placebo was provided in pre-filled 1 mL syringes.

Trial Locations (40)

1200

Novartis Investigative Site, Brussels

2010

Novartis Investigative Site, Sydney

3002

Novartis Investigative Site, East Melbourne

4000

Novartis Investigative Site, Liège

4102

Novartis Investigative Site, Woolloongabba

16635

Novartis Investigative Site, Duncansville

20354

Novartis Investigative Site, Hamburg

24105

Novartis Investigative Site, Kiel

27262

Novartis Investigative Site, High Point

28006

Novartis Investigative Site, Madrid

28031

Novartis Investigative Site, Madrid

28041

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

33647

Novartis Investigative Site, Bielefeld

35233

Novartis Investigative Site, Birmingham

37203

Novartis Investigative Site, Nashville

46017

Novartis Investigative Site, Valencia

46256

Novartis Investigative Site, Indianapolis

48143

Novartis Investigative Site, Münster

48455

Novartis Investigative Site, Bad Bentheim

48903

Novartis Investigative Site, Barakaldo

60077

Novartis Investigative Site, Skokie

71110

Novartis Investigative Site, Heraklion, Crete

77030

Novartis Investigative Site, Houston

85032

Novartis Investigative Site, Phoenix

97210

Novartis Investigative Site, Portland

400 11

Novartis Investigative Site, Ústí nad Labem

100 34

Novartis Investigative Site, Prague

DK-8000

Novartis Investigative Site, Arhus C

DK-2400

Novartis Investigative Site, Copenhagen NV

DK-2900

Novartis Investigative Site, Hellerup

161 21

Novartis Investigative Site, Athens

08208

Novartis Investigative Site, Sabadell

08003

Novartis Investigative Site, Barcelona

E11 1NR

Novartis Investigative Site, London

WS11 5XY

Novartis Investigative Site, Staffordshire

DY1 2HQ

Novartis Investigative Site, Dudley

B15 2TH

Novartis Investigative Site, Birmingham

L14 3PE

Novartis Investigative Site, Liverpool

NE1 4LP

Novartis Investigative Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY